gut.bmj3月
A randomised, double-blind trial comparing budesonide formulations and dosages for short ...
for orodispersible use versus oral budesonide viscous suspension (BVS) 2×5 mL/day (0.4 mg/mL) for short-term induction treatment of active EoE. Histological remission occurred in 100%, 94.7%, 94.7% ...